This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The diversified healthcare conglomerate sells pharmaceuticals, medical devices, and various other products worldwide through its two units: Innovative Medicine and MedTech. The company is famous for having the highest credit rating available -- higher than the U.S. The stock offers a solid blend of income and growth.
Study the management team and board of directors Publiccompanies are obligated to apprise investors of who is on their management team, as well as provide the identities of prominent board members, directors, and major shareholders. So don't hesitate to buy competing businesses, as it often isn't contradictory in any way.
This could be a very important year in investing, given what this tech company has gone on to do. Fast forward to 2013. I would retort, look, when sales are growing north of 40% annually, cash flow margins are 50-60%, and there's still a 7-10 year tailwind behind this company? David Gardner: The Facebook. I say, yes.
Adobe in 2013 with its Creative Cloud offering, began to shift the model. Is this a company you've studied? Yasser El-Shimy: It is not a company I have studied. In this city when you think of publiccompanies based in Washington, DC, any standout performers come to mind for you? That's how Marriott started.
RITHOLTZ: Whereas all the other publiccompanies had access to capital and managed to get into trouble. RITHOLTZ: So, you go from Lazard to Merrill to JPMorgan, tell us about those other experiences, how do they compare to Lazard which seems much more unique, being in a publiccompany versus a partnership. RITHOLTZ: Sure.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content